Zenotech Laboratories Ltd. - Research Center
532039 ZENOTECH Group (XT) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 61.03 |
61.03 |
61.03 |
61.03 |
61.03 |
Share application money
Preference share capital
Reserves & surplus
| 35.10 |
29.51 |
21.24 |
9.61 |
-12.62 |
Secured loans
Unsecured loans
Total
| 96.13 |
90.54 |
82.27 |
76.64 |
69.06 |
Gross block
| 116.29 |
114.05 |
106.78 |
105.13 |
101.48 |
Less : revaluation reserve
Less : accumulated depreciation
| 55.43 |
48.47 |
41.39 |
34.22 |
27.25 |
Net block
| 60.87 |
65.58 |
65.38 |
70.91 |
74.23 |
Capital work-in-progress
Investments
Current assets, loans & advances
| 46.59 |
38.67 |
30.51 |
22.90 |
9.43 |
Less : current liabilities & provisions
| 14.90 |
15.66 |
18.60 |
17.44 |
16.78 |
Total net current assets
| 31.69 |
23.00 |
11.91 |
5.45 |
-7.35 |
Miscellaneous expenses not written
Total
| 96.13 |
90.54 |
82.27 |
76.64 |
69.06 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
| 16.20 |
15.06 |
20.88 |
11.27 |
10.82 |
Number of equity sharesoutstanding (Lacs)
| 610.31 |
610.31 |
610.31 |
610.31 |
610.31 |